Risk for sudden cardiac death increased among people living with HIV with elevated HIV viral load or low CD4 cell counts.
Investigators conducted a retrospective cohort study to determine the difference in COVID-19 outcomes in patients with HIV infection compared with those without HIV infection.
An appropriate vaccination strategy will follow.
As HIV-exposed, uninfected infants have higher rates of morbidity and mortality than HIV-unexposed uninfected infants, a study was conducted to analyze whether particular infections or immune responses contribute to hospitalization.
Researchers used global baseline data to examine cardiovascular disease risk factors among middle-aged people with HIV.
A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.
Findings emphasize the importance of strategies to help HBV-HIV coinfected patients maximize antiretroviral adherence to achieve hepatitis B viral suppression.
Researchers assessed the influence of direct-acting antivirals on gut microbiota by analyzing microbial diversity and composition in patients with hepatitis C virus infection with or without HIV.
Patients on PrEP are more likely to engage in risky sexual behavior than patients not on PrEP, this is also true for members of the LGBTQ community in NYC.
Investigators sought to identify variables that influence condom use likelihood with carrying serostatus partners to learn about HIV prevention strategies.
Study authors described racial disparities related to the HIV epidemic and compared key findings with the COVID-19 pandemic.
HIV prevalence varied by race and ethnicity and was 17% and 62% among White and Black transgender individuals, respectively.
Study authors studied respiratory samples and sera for SARS-CoV-2 in 3 deeply immunocompromised patients.
Women living with HIV have a unique set of mental health risks and stressors, but are their needs being met? Healthcare providers should be aware of these 5 ways that women with HIV are experiencing detriments to their mental health.
Researchers aimed to estimate the prevalence of liver fibrosis and factors associated with it in people living with HIV compared with those in a control group.
According to this systematic review, sexual and gender minority patients may be at risk for several neurologic deficiencies.
Investigators used data from mothers and infants enrolled in the DolPHIN-1 trial to develop a population pharmacokinetic model of dolutegravir.
The goal of this study was to assess the impact of doxycycline PEP on M genitalium, an emerging pathogen among men who have sex with men that has rising rates of antibiotic resistance.
Persons living with HIV who are diagnosed with COVID-19 are more likely to require hospitalization and to die.
The HIV Medicine Association of the Infectious Diseases Society of America published an updated primary care guidance for persons with HIV.